Skip to main content

Diabetes-related weight loss drugs facing supply issues amid viral trend

Novo Nordisk, which manufactures the antidiabetic drugs Ozempic and Wegovy, told FOX Business it's facing supply issues due to "unprecedented demand" on top of global supply constraints.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.